Interferon resistance of emerging SARS-CoV-2 variants

被引:66
作者
Guo, Kejun [1 ]
Barrett, Bradley S. [1 ]
Morrison, James H. [1 ]
Mickens, Kaylee L. [1 ,2 ]
Vladar, Eszter K. [3 ]
Hasenkrug, Kim J. [4 ]
Poeschla, Eric M. [1 ,2 ]
Santiago, Mario L. [1 ,2 ]
机构
[1] Univ Colorado, Div Infect Dis, Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA
[2] Univ Colorado, Dept Immunol & Microbiol, Anschutz Med Campus, Aurora, CO 80045 USA
[3] Univ Colorado, Dept Med, Div Pulm Sci & Crit Care Med, Anschutz Med Campus, Aurora, CO 80045 USA
[4] NIAID, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA
基金
美国国家卫生研究院;
关键词
SARS-CoV-2; COVID-19; interferons; innate immunity; variants of concern; I INTERFERON; ALPHA; IFN; LANDSCAPE; EMERGENCE; INFECTION; RESPONSES; SUBTYPES; LINEAGE; BETA;
D O I
10.1073/pnas.2203760119
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The emergence of SARS-CoV-2 variants with enhanced transmissibility, pathogenesis, and resistance to vaccines presents urgent challenges for curbing the COVID-19 pandemic. While Spike mutations that enhance virus infectivity or neutralizing antibody evasion may drive the emergence of these novel variants, studies documenting a critical role for interferon responses in the early control of SARS-CoV-2 infection, combined with the presence of viral genes that limit these responses, suggest that interferons may also influence SARS-CoV-2 evolution. Here, we compared the potency of 17 different human interferons against multiple viral lineages sampled during the course of the global outbreak, including ancestral and five major variants of concern that include the B.1.1.7 (alpha), B.1.351 (beta), P.1 (gamma), B.1.617.2 (delta), and B.1.1.529 (omicron) lineages. Our data reveal that relative to ancestral isolates, SARS-CoV-2 variants of concern exhibited increased interferon resistance, suggesting that evasion of innate immunity may be a significant, ongoing driving force for SARS-CoV-2 evolution. These findings have implications for the increased transmissibility and/or lethality of emerging variants and highlight the interferon subtypes that may be most successful in the treatment of early infections.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Interferon antagonists encoded by SARS-CoV-2 at a glance
    Lee, Jung-Hyun
    Koepke, Lennart
    Kirchhoff, Frank
    Sparrer, Konstantin M. J.
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2023, 212 (02) : 125 - 131
  • [42] Comparative phylodynamics reveals the evolutionary history of SARS-CoV-2 emerging variants in the Arabian Peninsula
    Alkhamis, Moh A.
    Fountain-Jones, Nicholas M.
    Khajah, Mohammad M.
    Alghounaim, Mohammad
    Al-Sabah, Salman K.
    VIRUS EVOLUTION, 2022, 8 (01)
  • [43] Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy
    Ramesh, Sindhu
    Govindarajulu, Manoj
    Parise, Rachel S.
    Neel, Logan
    Shankar, Tharanath
    Patel, Shriya
    Lowery, Payton
    Smith, Forrest
    Dhanasekaran, Muralikrishnan
    Moore, Timothy
    VACCINES, 2021, 9 (10)
  • [44] Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
    Fernandes, Queenie
    Inchakalody, Varghese Philipose
    Merhi, Maysaloun
    Mestiri, Sarra
    Taib, Nassiba
    El-Ella, Dina Moustafa Abo
    Bedhiafi, Takwa
    Raza, Afsheen
    Al-Zaidan, Lobna
    Mohsen, Mona O.
    Al-Nesf, Mariam Ali Yousuf
    Hssain, Ali Ait
    Yassine, Hadi Mohamad
    Bachmann, Martin F.
    Uddin, Shahab
    Dermime, Said
    ANNALS OF MEDICINE, 2022, 54 (01) : 524 - 540
  • [45] Immune evasion of SARS-CoV-2 from interferon antiviral system
    Min, Yuan-Qin
    Huang, Mengzhuo
    Sun, Xiulian
    Deng, Fei
    Wang, Hualin
    Ning, Yun-Jia
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2021, 19 : 4217 - 4225
  • [46] COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
    Raman, Renuka
    Patel, Krishna J.
    Ranjan, Kishu
    BIOMOLECULES, 2021, 11 (07)
  • [47] SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines
    Li, Xi
    Mi, Ze
    Liu, Zhenguo
    Rong, Pengfei
    FRONTIERS IN MICROBIOLOGY, 2024, 15
  • [48] Characterizing the Severity of SARS-CoV-2 Variants at a Single Pediatric Center
    Khan, Aslam
    Ichura, Caroline
    Wang, Hannah
    Rezende, Izabela
    Sahoo, Malaya K.
    Huang, ChunHong
    Solis, Daniel
    Sibai, Mamdouh
    Yamamoto, Fumiko
    Nyathi, Sindiso
    Bayrau, Bethel
    Pinsky, Benjamin A.
    LaBeaud, A. Desiree
    FRONTIERS IN MEDICINE, 2022, 9
  • [49] Evolution, correlation, structural impact and dynamics of emerging SARS-CoV-2 variants
    Spratt, Austin N.
    Kannan, Saathvik R.
    Woods, Lucas T.
    Weisman, Gary A.
    Quinn, Thomas P.
    Lorson, Christian L.
    Sonnerborg, Anders
    Byrareddy, Siddappa N.
    Singh, Kamal
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2021, 19 : 3799 - 3809
  • [50] SARS-COV-2 VARIANTS AND THE SO-CALLED RESISTANCE TO VACCINES
    Kantor, Isabel N.
    Luthy, Isabel A.
    Ritacco, Viviana
    MEDICINA-BUENOS AIRES, 2021, 81 (03) : 421 - 426